
Blueprint Medicines Corporation BPMC
Blueprint Medicines Corporation PEG | BPMC
PEG Jährlich Blueprint Medicines Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -120 | -37.8 | -0.516 | -2.75 | 5.15 | 0.253 | 0.35 | 0.426 | -0.899 | 0.285 | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.15 | -120 | -15.5 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Provention Bio
PRVB
|
-1.02 | - | - | $ 2.37 B | ||
|
Reata Pharmaceuticals
RETA
|
-0.527 | - | - | $ 6.29 B | ||
|
PainReform Ltd.
PRFX
|
-0.00083 | $ 0.47 | -24.53 % | $ 305 K | ||
|
iTeos Therapeutics
ITOS
|
-0.295 | - | - | $ 411 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 1.44 | -2.03 % | $ 2.37 M | ||
|
PolarityTE
PTE
|
-0.00304 | - | -0.82 % | $ 1.78 M | ||
|
Kronos Bio
KRON
|
-0.15 | - | 1.49 % | $ 50.8 M | ||
|
Cullinan Management
CGEM
|
0.034 | $ 8.9 | -1.93 % | $ 536 M | ||
|
CRISPR Therapeutics AG
CRSP
|
0.0973 | $ 39.15 | 0.57 % | $ 3.52 B | ||
|
Advaxis
ADXS
|
-0.00008 | - | -9.65 % | $ 45.9 M | ||
|
Stoke Therapeutics
STOK
|
28.1 | $ 26.77 | -0.59 % | $ 1.59 B | ||
|
Trevena
TRVN
|
-0.000183 | - | -46.58 % | $ 31.8 M | ||
|
Calithera Biosciences
CALA
|
-0.00162 | - | -10.95 % | $ 876 K | ||
|
Molecular Templates
MTEM
|
-0.00416 | - | -23.43 % | $ 495 K | ||
|
Oncorus
ONCR
|
0.0156 | - | -8.54 % | $ 3.19 M | ||
|
BioXcel Therapeutics
BTAI
|
-0.000761 | $ 0.07 | 9.81 % | $ 855 K | ||
|
Novan
NOVN
|
-0.00284 | - | -24.84 % | $ 2.64 M | ||
|
CohBar
CWBR
|
-0.000901 | - | -15.44 % | $ 2.2 M | ||
|
NeuBase Therapeutics
NBSE
|
0.00351 | - | -1.56 % | $ 12.3 M | ||
|
Epizyme
EPZM
|
-0.122 | - | - | $ 249 M | ||
|
Arena Pharmaceuticals
ARNA
|
-0.000409 | - | -6.81 % | $ 3.04 B | ||
|
Scopus BioPharma
SCPS
|
0.036 | - | -48.37 % | $ 3.71 M | ||
|
Nabriva Therapeutics plc
NBRV
|
-0.000204 | - | - | $ 4.55 M | ||
|
Annovis Bio
ANVS
|
-0.0781 | $ 0.71 | -3.81 % | $ 14.6 M | ||
|
scPharmaceuticals
SCPH
|
-2.51 | - | - | $ 218 M | ||
|
Entasis Therapeutics Holdings
ETTX
|
0.123 | - | - | $ 105 M | ||
|
Athersys
ATHX
|
-0.000135 | - | 3.77 % | $ 22.4 M | ||
|
Global Blood Therapeutics
GBT
|
-0.422 | - | - | $ 4.62 B | ||
|
Inozyme Pharma
INZY
|
-0.0361 | - | - | $ 207 M | ||
|
NanoString Technologies
NSTG
|
-0.154 | - | -37.43 % | $ 5.1 M | ||
|
Humanigen
HGEN
|
-0.00141 | - | -81.12 % | $ 4.28 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.000003 | $ 3.56 | -9.07 % | $ 1.58 M | ||
|
Sorrento Therapeutics
SRNE
|
0.018 | - | -29.58 % | $ 126 M | ||
|
Surface Oncology
SURF
|
0.0307 | - | - | $ 59.7 M | ||
|
Sierra Oncology
SRRA
|
-0.00778 | - | -0.05 % | $ 1.34 B | ||
|
Vaccinex
VCNX
|
-0.000064 | - | -61.37 % | $ 654 K | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
0.229 | - | -19.68 % | $ 18.4 M | ||
|
Jounce Therapeutics
JNCE
|
0.0118 | - | - | $ 98.4 M | ||
|
Cocrystal Pharma
COCP
|
-0.00606 | $ 0.93 | -4.11 % | $ 10.5 M | ||
|
Fortress Biotech
FBIO
|
0.00811 | $ 1.89 | 6.78 % | $ 52.7 M | ||
|
Acorda Therapeutics
ACOR
|
-0.000085 | - | -24.86 % | $ 820 K | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000175 | - | -11.43 % | $ 502 K | ||
|
Immunic
IMUX
|
0.0859 | $ 7.0 | -5.28 % | $ 1.09 B | ||
|
Immunovant
IMVT
|
0.000003 | $ 31.74 | -2.4 % | $ 5.79 B | ||
|
Mersana Therapeutics
MRSN
|
0.0284 | - | - | $ 3.56 B | ||
|
Akari Therapeutics, Plc
AKTX
|
13.5 | $ 6.83 | 1.71 % | $ 460 B | ||
|
MediWound Ltd.
MDWD
|
0.0499 | $ 13.59 | 0.33 % | $ 370 M | ||
|
CymaBay Therapeutics
CBAY
|
-15.6 | - | - | $ 3.45 B | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-0.0155 | - | - | $ 384 M |